- Home
- ELWS vs ALUR Comparison
ELWS vs ALUR Comparison
Compare ELWS & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ELWS | ALUR |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4M | 15.4M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELWS | ALUR |
|---|---|---|
| Price | $5.46 | $1.58 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.25 |
| AVG Volume (30 Days) | 24.9K | ★ 125.4K |
| Earning Date | 12-31-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,083,071.00 | ★ $17,208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 145.52 | N/A |
| 52 Week Low | $1.64 | $1.02 |
| 52 Week High | $10.50 | $16.81 |
Technical Indicators
Market Signals| Indicator | ELWS | ALUR |
|---|---|---|
| Relative Strength Index (RSI) | 55.46 | 47.45 |
| Support Level | $5.38 | $1.61 |
| Resistance Level | $6.11 | $1.75 |
| Average True Range (ATR) | 0.30 | 0.17 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 48.38 | 70.78 |
Price Performance
Historical ComparisonAbout ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.